FAB-144 is an indazole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug.[1] It is the indazole analogue of XLR-11.
Sweden's public health agency suggested classifying FAB-144 as a hazardous substance on November 10, 2014.[2]
This cannabinoid related article is a stub. You can help Wikipedia by expanding it.